Researchers at Washington University in St. Louis have developed a microneedle patch that can help detect small amounts of antibodies in interstitial fluid. The researchers used fluorescence nanolabels to detect protein biomarkers present in small amounts in interstitial fluid. The signal from the target biomarkers in samples was approximately 1,400 times brighter than that from conventional fluorescent labels.
An official website of the United States government.